Source link : https://www.newshealth.biz/health-news/rheumatology-meds-seen-cutting-amd-risk/
Insurance claims data showed that patients with autoimmune disorders who took Janus kinase (JAK) inhibitors had lower rates of age-related macular degeneration (AMD), hinting that the drugs might treat the common eye disease. Compared to patients on other immune-modulating drugs, those taking JAK inhibitors had lower rates of AMD over 6-18 months in two administrative […]
Author : News Health
Publish date : 2024-07-11 15:00:00
Copyright for syndicated content belongs to the linked Source.
Categories